Insider Trading › CRNX › Insiders
CRNX
CRNX·Insider activity
—
No end-of-day price on record
CRNX
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CRNXS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, CRNX insiders filed 0 purchases ($0) and 3 sales ($366K) on the open market, by 2 insiders. Newest filing Jul 7, 2026 (3 months ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by CRNX insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$366KSales · 180 days
201Open-market transactions on record
2Insiders filing · 180 days
Purchases (code P) and sales (code S) of CRNX common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
201 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Vivaldi Coelho RogerioDirector · Director | Sale | −3,000 | $40.00 | $120K | 19.2Kdirect | Jul 2, 2026 | Jul 7, 2026 | Form 4 ↗ |
| Okey StephanieDirector | Sale | −608 | $36.22 | $22K | 6,400direct | Jun 17, 2026 | Jun 18, 2026 | Form 4 ↗ |
| Okey StephanieDirector | Sale | −6,292 | $35.62 | $224K | 7,008direct | Jun 17, 2026 | Jun 18, 2026 | Form 4 ↗ |
| Knight Jeff E.Chief Dev. & Operating Officer | Sale | −85.2K | $40.10 | $3.4M | 105.3Kdirect | Apr 8, 2026 | Apr 10, 2026 | Form 4 ↗ |
| Knight Jeff E.Chief Operating Officer | Sale | −3,961 | $37.77 | $150K | 112.0Kdirect | Mar 16, 2026 | Mar 18, 2026 | Form 4 ↗ |
| Knight Jeff E.Chief Operating Officer | Sale | −5,950 | $37.11 | $221K | 116.0Kdirect | Mar 16, 2026 | Mar 18, 2026 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −4,241 | $37.77 | $160K | 137.1Kdirect | Mar 16, 2026 | Mar 18, 2026 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −6,371 | $37.11 | $236K | 141.3Kdirect | Mar 16, 2026 | Mar 18, 2026 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −8,785 | $37.77 | $332K | 404.8Kdirect | Mar 16, 2026 | Mar 18, 2026 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −13.2K | $37.11 | $490K | 413.6Kdirect | Mar 16, 2026 | Mar 18, 2026 | Form 4 ↗ |
| Vivaldi Coelho RogerioDirector | Sale | −523 | $36.77 | $19K | 16.3Kdirect | Mar 12, 2026 | Mar 13, 2026 | Form 4 ↗ |
| Vivaldi Coelho RogerioDirector | Sale | −4,477 | $36.08 | $162K | 16.8Kdirect | Mar 12, 2026 | Mar 13, 2026 | Form 4 ↗ |
| Okey StephanieDirector | Sale | −3,000 | $39.67 | $119K | 13.3Kdirect | Mar 3, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Schilke TobinChief Financial Officer | Sale | −6,713 | $39.67 | $266K | 78.1Kdirect | Mar 3, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Kalofonos IsabelChief Commercial Officer | Sale | −2,500 | $55.00 | $138K | 834direct | Jan 5, 2026 | Jan 7, 2026 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −5,000 | $45.02 | $225K | 66.8Kdirect | Dec 1, 2025 | Dec 3, 2025 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −100 | $43.27 | $4K | 66.3Kdirect | Nov 3, 2025 | Nov 5, 2025 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −4,900 | $42.65 | $209K | 66.4Kdirect | Nov 3, 2025 | Nov 5, 2025 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −5,000 | $41.81 | $209K | 66.3Kdirect | Oct 1, 2025 | Oct 3, 2025 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −4,000 | $45.00 | $180K | 106.0Kindirect | Sep 26, 2025 | Sep 30, 2025 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −16.0K | $44.75 | $716K | 22.8Kdirect | Sep 26, 2025 | Sep 30, 2025 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −5,000 | $32.10 | $161K | 96.3Kdirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −30.0K | $30.43 | $913K | 66.3Kdirect | Aug 22, 2025 | Aug 26, 2025 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −6,492 | $29.18 | $189K | 66.3Kdirect | Aug 20, 2025 | Aug 21, 2025 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −97.5K | $32.23 | $3.1M | 99.7Kdirect | Jun 12, 2025 | Jun 16, 2025 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −127 | $34.83 | $4K | 72.2Kdirect | Mar 19, 2025 | Mar 21, 2025 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −2,388 | $34.17 | $82K | 72.4Kdirect | Mar 19, 2025 | Mar 21, 2025 | Form 4 ↗ |
| Knight Jeff E.Chief Operating Officer | Sale | −361 | $34.83 | $13K | 87.5Kdirect | Mar 19, 2025 | Mar 21, 2025 | Form 4 ↗ |
| Knight Jeff E.Chief Operating Officer | Sale | −6,801 | $34.17 | $232K | 87.9Kdirect | Mar 19, 2025 | Mar 21, 2025 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −291 | $34.83 | $10K | 108.6Kdirect | Mar 19, 2025 | Mar 21, 2025 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −5,479 | $34.17 | $187K | 108.9Kdirect | Mar 19, 2025 | Mar 21, 2025 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −875 | $34.83 | $30K | 329.1Kdirect | Mar 19, 2025 | Mar 21, 2025 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −16.5K | $34.17 | $563K | 330.0Kdirect | Mar 19, 2025 | Mar 21, 2025 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −5,000 | $39.07 | $195K | 31.7Kdirect | Feb 3, 2025 | Feb 5, 2025 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −15.0K | $52.09 | $781K | 29.2Kdirect | Jan 3, 2025 | Jan 7, 2025 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −10.0K | $57.57 | $576K | 100.0Kindirect | Dec 2, 2024 | Dec 4, 2024 | Form 4 ↗ |
| Knight Jeff E.Chief Operating Officer | Sale | −501 | $56.52 | $28K | 51.7Kdirect | Nov 22, 2024 | Nov 26, 2024 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −14.4K | $54.63 | $785K | 28.5Kdirect | Oct 3, 2024 | Oct 7, 2024 | Form 4 ↗ |
| Wilson MarcCFO | Sale | −25.0K | $51.11 | $1.3M | 111.1Kdirect | Sep 26, 2024 | Sep 30, 2024 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −1,035 | $51.50 | $53K | 68.6Kdirect | Sep 10, 2024 | Sep 12, 2024 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,000 | $53.19 | $160K | 69.6Kdirect | Aug 26, 2024 | Aug 28, 2024 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,000 | $47.68 | $143K | 72.6Kdirect | Aug 12, 2024 | Aug 14, 2024 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,000 | $53.43 | $160K | 75.6Kdirect | Jul 25, 2024 | Jul 26, 2024 | Form 4 ↗ |
| Wilson MarcCFO | Sale | −19.1K | $53.88 | $1.0M | 111.1Kdirect | Jul 25, 2024 | Jul 26, 2024 | Form 4 ↗ |
| Knight Jeff E.Chief Operating Officer | Sale | −27.0K | $55.00 | $1.5M | 51.7Kdirect | Jul 15, 2024 | Jul 17, 2024 | Form 4 ↗ |
| Wilson MarcCFO | Sale | −25.0K | $55.00 | $1.4M | 111.1Kdirect | Jul 15, 2024 | Jul 17, 2024 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,000 | $48.55 | $146K | 78.6Kdirect | Jul 10, 2024 | Jul 12, 2024 | Form 4 ↗ |
| Hassard JamesChief Commercial Officer | Sale | −15.0K | $44.08 | $661K | 29.3Kdirect | Jul 5, 2024 | Jul 9, 2024 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −14.4K | $44.87 | $645K | 28.5Kdirect | Jul 3, 2024 | Jul 5, 2024 | Form 4 ↗ |
| Wilson MarcCFO | Sale | −32.1K | $43.61 | $1.4M | 111.1Kdirect | Jun 28, 2024 | Jul 2, 2024 | Form 4 ↗ |
| Knight Jeff E.Chief Operating Officer | Sale | −956 | $44.38 | $42K | 52.6Kdirect | Jun 26, 2024 | Jun 28, 2024 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,000 | $45.37 | $136K | 80.6Kdirect | Jun 25, 2024 | Jun 26, 2024 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −9,500 | $45.73 | $434K | 27.8Kdirect | Jun 24, 2024 | Jun 25, 2024 | Form 4 ↗ |
| Hassard JamesChief Commercial Officer | Sale | −15.0K | $44.66 | $670K | 29.3Kdirect | Jun 21, 2024 | Jun 24, 2024 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,000 | $43.86 | $132K | 83.6Kdirect | Jun 10, 2024 | Jun 11, 2024 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,000 | $47.49 | $142K | 86.6Kdirect | May 28, 2024 | May 30, 2024 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,000 | $49.43 | $148K | 89.6Kdirect | May 10, 2024 | May 14, 2024 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −107.4K | $49.40 | $5.3M | 257.5Kdirect | May 8, 2024 | May 10, 2024 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −14.4K | $44.47 | $639K | 27.8Kdirect | Apr 15, 2024 | Apr 17, 2024 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −41.0K | $49.17 | $2.0M | 237.8Kdirect | Apr 4, 2024 | Apr 8, 2024 | Form 4 ↗ |
| Okey StephanieDirector | Sale | −17.5K | $46.38 | $812K | 6,000direct | Mar 28, 2024 | Apr 2, 2024 | Form 4 ↗ |
| Knight Jeff E.Chief Operating Officer | Sale | −2,359 | $45.39 | $107K | 52.6Kdirect | Mar 22, 2024 | Mar 26, 2024 | Form 4 ↗ |
| Knight Jeff E.Chief Operating Officer | Sale | −30.0K | $44.22 | $1.3M | 54.9Kdirect | Mar 22, 2024 | Mar 26, 2024 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −714 | $43.69 | $31K | 27.8Kdirect | Mar 20, 2024 | Mar 22, 2024 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −10.0K | $43.28 | $433K | 28.5Kdirect | Mar 20, 2024 | Mar 22, 2024 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −4,375 | $45.89 | $201K | 28.5Kdirect | Mar 20, 2024 | Mar 22, 2024 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −17.5K | $45.50 | $796K | 18.5Kdirect | Mar 20, 2024 | Mar 22, 2024 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −17.5K | $43.58 | $763K | 18.5Kdirect | Mar 20, 2024 | Mar 22, 2024 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −12.5K | $43.57 | $545K | 18.5Kdirect | Mar 20, 2024 | Mar 22, 2024 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −12.5K | $43.57 | $545K | 18.5Kdirect | Mar 20, 2024 | Mar 22, 2024 | Form 4 ↗ |
| Wilson MarcCFO | Sale | −6,942 | $42.91 | $298K | 110.6Kdirect | Mar 19, 2024 | Mar 20, 2024 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,000 | $37.26 | $112K | 73.3Kdirect | Jan 25, 2024 | Jan 26, 2024 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,000 | $37.65 | $113K | 76.3Kdirect | Jan 10, 2024 | Jan 12, 2024 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −14.4K | $35.00 | $503K | 5,911direct | Jan 3, 2024 | Jan 4, 2024 | Form 4 ↗ |
| Wilson MarcCFO | Sale | −10.0K | $35.47 | $355K | 96.1Kdirect | Jan 2, 2024 | Jan 4, 2024 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,000 | $35.89 | $108K | 79.3Kdirect | Dec 26, 2023 | Dec 27, 2023 | Form 4 ↗ |
| Pizzuti DanaChief Med and Dev Officer | Sale | −9,583 | $34.57 | $331K | 5,911direct | Dec 21, 2023 | Dec 22, 2023 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,000 | $32.87 | $99K | 82.3Kdirect | Dec 11, 2023 | Dec 13, 2023 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,000 | $31.84 | $96K | 85.3Kdirect | Nov 27, 2023 | Nov 29, 2023 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −199.1K | $30.56 | $6.1M | 135.5Kdirect | Nov 3, 2023 | Nov 6, 2023 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −918 | $29.95 | $27K | 135.5Kdirect | Nov 2, 2023 | Nov 6, 2023 | Form 4 ↗ |
| Wilson MarcCFO | Sale | −10.0K | $28.75 | $288K | 95.6Kdirect | Nov 1, 2023 | Nov 3, 2023 | Form 4 ↗ |
| Krasner Alan SethChief Medical Officer | Sale | −7,000 | $30.00 | $210K | 43.2Kdirect | Oct 17, 2023 | Oct 19, 2023 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −14.2K | $20.35 | $288K | 630.8Kindirect | Jul 13, 2023 | Jul 13, 2023 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −11.5K | $20.17 | $231K | 645.0Kindirect | Jul 12, 2023 | Jul 13, 2023 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −24.4K | $20.14 | $491K | 656.4Kindirect | Jul 11, 2023 | Jul 13, 2023 | Form 4 ↗ |
| Wilson MarcCFO | Sale | −20.0K | $19.97 | $399K | 95.2Kdirect | Jun 20, 2023 | Jun 21, 2023 | Form 4 ↗ |
| Wilson MarcCFO | Sale | −10.9K | $19.96 | $218K | 95.2Kdirect | Jun 20, 2023 | Jun 21, 2023 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −50.0K | $20.81 | $1.0M | 680.8Kindirect | Jun 16, 2023 | Jun 21, 2023 | Form 4 ↗ |
| Vivaldi Coelho RogerioDirector | Purchase | +5,000 | $22.06 | $110K | 5,000direct | Jun 8, 2023 | Jun 9, 2023 | Form 4 ↗ |
| Pizzuti DanaChief Development Officer | Sale | −8,212 | $16.15 | $133K | 4,500direct | Apr 5, 2023 | Apr 5, 2023 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,126 | $19.59 | $61K | 64.7Kdirect | Feb 1, 2023 | Feb 3, 2023 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −8,336 | $21.07 | $176K | 67.8Kdirect | Jan 25, 2023 | Jan 27, 2023 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,126 | $18.00 | $56K | 76.2Kdirect | Jan 17, 2023 | Jan 19, 2023 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,126 | $18.35 | $57K | 79.3Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,126 | $16.00 | $50K | 82.4Kdirect | Dec 15, 2022 | Dec 19, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,126 | $17.84 | $56K | 85.0Kdirect | Dec 1, 2022 | Dec 5, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,126 | $18.72 | $59K | 88.1Kdirect | Nov 15, 2022 | Nov 17, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,126 | $18.52 | $58K | 91.2Kdirect | Nov 1, 2022 | Nov 3, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,126 | $17.73 | $55K | 94.3Kdirect | Oct 17, 2022 | Oct 19, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,126 | $19.64 | $61K | 97.5Kdirect | Oct 3, 2022 | Oct 5, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −4,168 | $21.01 | $88K | 100.6Kdirect | Sep 15, 2022 | Sep 19, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −1,042 | $21.00 | $22K | 104.8Kdirect | Sep 7, 2022 | Sep 9, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,126 | $18.59 | $58K | 105.8Kdirect | Sep 1, 2022 | Sep 6, 2022 | Form 4 ↗ |
| Knight Jeff E.Chief Operating Officer | Sale | −1,152 | $20.70 | $24K | 4,950direct | Jul 26, 2022 | Jul 29, 2022 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −5,700 | $20.96 | $119K | 12.5Kdirect | Jul 13, 2022 | Jul 15, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,247 | $20.10 | $65K | 107.6Kdirect | May 2, 2022 | May 4, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −5,664 | $25.81 | $146K | 110.8Kdirect | Apr 18, 2022 | Apr 21, 2022 | Form 4 ↗ |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD10% owner | Purchase | +157.5K | $22.22 | $3.5M | 5.3Mindirect | Apr 18, 2022 | Apr 18, 2022 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −69.2K | $27.53 | $1.9M | 730.8Kindirect | Apr 13, 2022 | Apr 15, 2022 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −44.8K | $26.52 | $1.2M | 800.0Kindirect | Apr 13, 2022 | Apr 15, 2022 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −24.7K | $25.42 | $627K | 844.8Kindirect | Apr 13, 2022 | Apr 15, 2022 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −21.4K | $25.34 | $541K | 869.4Kindirect | Apr 5, 2022 | Apr 7, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −9,000 | $23.97 | $216K | 116.5Kdirect | Apr 4, 2022 | Apr 6, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −4,164 | $21.80 | $91K | 125.5Kdirect | Apr 1, 2022 | Apr 1, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −4,164 | $21.06 | $88K | 129.7Kdirect | Mar 31, 2022 | Apr 1, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,123 | $18.94 | $59K | 133.8Kdirect | Mar 15, 2022 | Mar 17, 2022 | Form 4 ↗ |
| Madan AjayChief Development Officer | Sale | +9,000 | $19.88 | $179K | 177.0Kdirect | Mar 1, 2022 | Mar 2, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,123 | $19.73 | $62K | 137.0Kdirect | Mar 1, 2022 | Mar 2, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,123 | $18.64 | $58K | 123.6Kdirect | Feb 15, 2022 | Feb 17, 2022 | Form 4 ↗ |
| Madan AjayChief Development Officer | Sale | −13.4K | $17.83 | $239K | 172.0Kdirect | Feb 7, 2022 | Feb 9, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,123 | $18.79 | $59K | 126.7Kdirect | Feb 1, 2022 | Feb 3, 2022 | Form 4 ↗ |
| Krasner Alan SethChief Medical Officer | Sale | −6,700 | $21.21 | $142K | 8,311direct | Jan 19, 2022 | Jan 21, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −4,168 | $23.29 | $97K | 128.9Kdirect | Jan 18, 2022 | Jan 20, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −7,168 | $28.02 | $201K | 133.0Kdirect | Jan 3, 2022 | Jan 6, 2022 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,000 | $27.95 | $84K | 140.2Kdirect | Dec 28, 2021 | Dec 30, 2021 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −5,668 | $24.14 | $137K | 143.2Kdirect | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −5,668 | $27.38 | $155K | 148.9Kdirect | Dec 1, 2021 | Dec 3, 2021 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −1,500 | $27.97 | $42K | 154.5Kdirect | Nov 16, 2021 | Nov 17, 2021 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −5,668 | $26.75 | $152K | 156.0Kdirect | Nov 15, 2021 | Nov 17, 2021 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,900 | $28.42 | $111K | 161.7Kdirect | Nov 8, 2021 | Nov 9, 2021 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −12.6K | $27.95 | $352K | 165.6Kdirect | Nov 5, 2021 | Nov 9, 2021 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −5,668 | $24.79 | $141K | 178.2Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −8,954 | $25.50 | $228K | 12.5Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −3,000 | $24.00 | $72K | 183.9Kdirect | Oct 27, 2021 | Oct 28, 2021 | Form 4 ↗ |
| EDELMAN JOSEPH10% owner | Purchase | +1.2M | n/c | — | 5.2Mindirect | Oct 25, 2021 | Oct 25, 2021 | Form 4 ↗ |
| Betz Stephen F.Chief Scientific Officer | Sale | −1,042 | $21.10 | $22K | 186.9Kdirect | Oct 21, 2021 | Oct 25, 2021 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −6,046 | $25.50 | $154K | 12.5Kdirect | Sep 8, 2021 | Sep 9, 2021 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −10.0K | $25.00 | $250K | 90.0Kindirect | Sep 7, 2021 | Sep 9, 2021 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −10.0K | $25.00 | $250K | 90.0Kindirect | Sep 7, 2021 | Sep 9, 2021 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −10.0K | $25.00 | $250K | 90.0Kindirect | Sep 7, 2021 | Sep 9, 2021 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −5,000 | $19.59 | $98K | 12.5Kdirect | Jul 26, 2021 | Jul 27, 2021 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −5,000 | $19.50 | $98K | 12.5Kdirect | Jul 19, 2021 | Jul 20, 2021 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −5,000 | $20.71 | $104K | 12.5Kdirect | Jul 12, 2021 | Jul 13, 2021 | Form 4 ↗ |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD10% owner | Purchase | +304.1K | $16.44 | $5.0M | 4.0Mindirect | Apr 8, 2021 | Apr 9, 2021 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Purchase | +4,000 | $13.10 | $52K | 4,000direct | Dec 3, 2020 | Dec 4, 2020 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Purchase | +1,000 | $12.60 | $13K | 1,000indirect | Dec 2, 2020 | Dec 4, 2020 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −17.5K | $14.46 | $253K | 890.8Kindirect | Jul 16, 2020 | Jul 17, 2020 | Form 4 ↗ |
| Struthers Richard ScottPresident & CEO · Director | Sale | −17.5K | $15.30 | $268K | 908.3Kindirect | Jul 15, 2020 | Jul 17, 2020 | Form 4 ↗ |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD10% owner | Purchase | +1.1M | $14.00 | $15.0M | 3.7Mindirect | Apr 17, 2020 | Apr 20, 2020 | Form 4 ↗ |
| Vivo Capital Surplus Fund VIII, L.P.10% owner | Sale | −10.3K | $15.40 | $158K | 298.6Kindirect | Apr 17, 2020 | Apr 17, 2020 | Form 4 ↗ |
| Vivo Capital Surplus Fund VIII, L.P.10% owner | Sale | −74.3K | $15.40 | $1.1M | 2.2Mindirect | Apr 17, 2020 | Apr 17, 2020 | Form 4 ↗ |
| Vivo Capital Surplus Fund VIII, L.P.10% owner | Sale | −3,663 | $15.20 | $56K | 308.9Kindirect | Apr 16, 2020 | Apr 17, 2020 | Form 4 ↗ |
| Vivo Capital Surplus Fund VIII, L.P.10% owner | Sale | −26.5K | $15.20 | $403K | 2.2Mindirect | Apr 16, 2020 | Apr 17, 2020 | Form 4 ↗ |
| Vivo Capital Surplus Fund VIII, L.P.10% owner | Sale | −26.2K | $15.50 | $406K | 312.6Kindirect | Apr 15, 2020 | Apr 17, 2020 | Form 4 ↗ |
| Vivo Capital Surplus Fund VIII, L.P.10% owner | Sale | −189.6K | $15.50 | $2.9M | 2.3Mindirect | Apr 15, 2020 | Apr 17, 2020 | Form 4 ↗ |
| Vivo Capital Fund VIII, L.P.10% owner | Sale | −742 | $14.20 | $11K | 338.7Kindirect | Apr 7, 2020 | Apr 7, 2020 | Form 4 ↗ |
| Vivo Capital Fund VIII, L.P.10% owner | Sale | −5,373 | $14.20 | $76K | 2.5Mindirect | Apr 7, 2020 | Apr 7, 2020 | Form 4 ↗ |
| Vivo Capital Fund VIII, L.P.10% owner | Sale | −36.4K | $13.80 | $502K | 339.5Kindirect | Apr 3, 2020 | Apr 7, 2020 | Form 4 ↗ |
| Vivo Capital Fund VIII, L.P.10% owner | Sale | −263.6K | $13.80 | $3.6M | 2.5Mindirect | Apr 3, 2020 | Apr 7, 2020 | Form 4 ↗ |
| Vivo Capital VIII, LLC10% owner | Sale | −133 | $19.50 | $3K | 168.2Kindirect | Mar 9, 2020 | Mar 11, 2020 | Form 4 ↗ |
| Vivo Capital VIII, LLC10% owner | Sale | −48 | $19.50 | $936 | 375.9Kindirect | Mar 9, 2020 | Mar 11, 2020 | Form 4 ↗ |
| Vivo Capital VIII, LLC10% owner | Sale | −347 | $19.50 | $7K | 2.7Mindirect | Mar 9, 2020 | Mar 11, 2020 | Form 4 ↗ |
| Vivo Capital VIII, LLC10% owner | Sale | −5,904 | $21.40 | $126K | 168.3Kindirect | Feb 10, 2020 | Feb 11, 2020 | Form 4 ↗ |
| Vivo Capital VIII, LLC10% owner | Sale | −200 | $21.40 | $4K | 375.9Kindirect | Feb 10, 2020 | Feb 11, 2020 | Form 4 ↗ |
| Vivo Capital VIII, LLC10% owner | Sale | −1,451 | $21.40 | $31K | 2.7Mindirect | Feb 10, 2020 | Feb 11, 2020 | Form 4 ↗ |
| Vivo Capital VIII, LLC10% owner | Sale | −4,614 | $22.00 | $102K | 174.2Kindirect | Feb 7, 2020 | Feb 11, 2020 | Form 4 ↗ |
| Vivo Capital VIII, LLC10% owner | Sale | −157 | $22.00 | $3K | 376.1Kindirect | Feb 7, 2020 | Feb 11, 2020 | Form 4 ↗ |
| Vivo Capital VIII, LLC10% owner | Sale | −1,134 | $22.00 | $25K | 2.7Mindirect | Feb 7, 2020 | Feb 11, 2020 | Form 4 ↗ |
| Vivo Capital Fund VIII, L.P.10% owner | Sale | −10.5K | $22.80 | $240K | 178.8Kindirect | Feb 4, 2020 | Feb 6, 2020 | Form 4 ↗ |
| Vivo Capital Fund VIII, L.P.10% owner | Sale | −357 | $22.80 | $8K | 376.3Kindirect | Feb 4, 2020 | Feb 6, 2020 | Form 4 ↗ |
| Vivo Capital Fund VIII, L.P.10% owner | Sale | −2,584 | $22.80 | $59K | 2.7Mindirect | Feb 4, 2020 | Feb 6, 2020 | Form 4 ↗ |
| Vivo Opportunity Fund, L.P.10% owner | Sale | −4,220 | $21.70 | $92K | 189.3Kindirect | Jan 31, 2020 | Jan 31, 2020 | Form 4 ↗ |
| Vivo Opportunity Fund, L.P.10% owner | Sale | −143 | $21.70 | $3K | 376.6Kindirect | Jan 31, 2020 | Jan 31, 2020 | Form 4 ↗ |
| Vivo Opportunity Fund, L.P.10% owner | Sale | −1,037 | $21.70 | $23K | 2.7Mindirect | Jan 31, 2020 | Jan 31, 2020 | Form 4 ↗ |
| Vivo Opportunity Fund, L.P.10% owner | Sale | −5,940 | $22.10 | $131K | 193.6Kindirect | Jan 30, 2020 | Jan 31, 2020 | Form 4 ↗ |
| Vivo Opportunity Fund, L.P.10% owner | Sale | −201 | $22.10 | $4K | 376.8Kindirect | Jan 30, 2020 | Jan 31, 2020 | Form 4 ↗ |
| Vivo Opportunity Fund, L.P.10% owner | Sale | −1,459 | $22.10 | $32K | 2.7Mindirect | Jan 30, 2020 | Jan 31, 2020 | Form 4 ↗ |
| Vivo Opportunity Fund, L.P.10% owner | Sale | −10.9K | $22.20 | $241K | 199.5Kindirect | Jan 29, 2020 | Jan 31, 2020 | Form 4 ↗ |
| Vivo Opportunity Fund, L.P.10% owner | Sale | −369 | $22.20 | $8K | 377.0Kindirect | Jan 29, 2020 | Jan 31, 2020 | Form 4 ↗ |
| Vivo Opportunity Fund, L.P.10% owner | Sale | −2,673 | $22.20 | $59K | 2.7Mindirect | Jan 29, 2020 | Jan 31, 2020 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −3,500 | $22.50 | $79K | 12.5Kdirect | Dec 16, 2019 | Dec 18, 2019 | Form 4 ↗ |
| ROCKLAGE SCOTT M | Sale | −10.0K | $22.20 | $222K | 94.5Kindirect | Jun 21, 2019 | Jun 25, 2019 | Form 4 ↗ |
| ROCKLAGE SCOTT M | Sale | −240.0K | $22.20 | $5.3M | 2.3Mindirect | Jun 21, 2019 | Jun 25, 2019 | Form 4 ↗ |
| Vivo Opportunity Fund, L.P.10% owner | Sale | −84.0K | n/c | — | 210.4Kindirect | Mar 20, 2019 | Mar 25, 2019 | Form 4 ↗ |
| Vivo Opportunity Fund, L.P.10% owner | Sale | −40.4K | n/c | — | 377.4Kindirect | Mar 20, 2019 | Mar 25, 2019 | Form 4 ↗ |
| Vivo Opportunity Fund, L.P.10% owner | Sale | −292.6K | n/c | — | 2.7Mindirect | Mar 20, 2019 | Mar 25, 2019 | Form 4 ↗ |
| ROCKLAGE SCOTT M10% owner | Sale | −6,194 | $24.25 | $150K | 104.5Kindirect | Mar 18, 2019 | Mar 20, 2019 | Form 4 ↗ |
| ROCKLAGE SCOTT M10% owner | Sale | −148.6K | $24.25 | $3.6M | 2.5Mindirect | Mar 18, 2019 | Mar 20, 2019 | Form 4 ↗ |
| DIEKMAN JOHN D10% owner | Sale | −10.5K | $21.88 | $229K | 129.5Kindirect | Jan 22, 2019 | Jan 24, 2019 | Form 4 ↗ |
| DIEKMAN JOHN D10% owner | Sale | −251.7K | $21.88 | $5.5M | 3.1Mindirect | Jan 22, 2019 | Jan 24, 2019 | Form 4 ↗ |
| PERCEPTIVE ADVISORS LLCDirector · 10% owner | Purchase Amended | +400.0K | n/c | — | 2.6Mindirect | Jul 20, 2018 | Aug 27, 2018 | Form 4 ↗ |
| Vivo Capital Fund VIII, L.P.10% owner | Purchase | +153.2K | $20.73 | $3.2M | 294.4Kindirect | Jul 20, 2018 | Jul 20, 2018 | Form 4 ↗ |
| Vivo Capital Fund VIII, L.P.10% owner | Purchase | +141.2K | n/c | — | 141.2Kindirect | Jul 20, 2018 | Jul 20, 2018 | Form 4 ↗ |
| Vivo Capital Fund VIII, L.P.10% owner | Purchase | +7,137 | n/c | — | 417.8Kindirect | Jul 20, 2018 | Jul 20, 2018 | Form 4 ↗ |
| Vivo Capital Fund VIII, L.P.10% owner | Purchase | +51.7K | n/c | — | 3.0Mindirect | Jul 20, 2018 | Jul 20, 2018 | Form 4 ↗ |
| ROCKLAGE SCOTT M10% owner | Purchase | +4,600 | n/c | — | 140.0Kindirect | Jul 20, 2018 | Jul 20, 2018 | Form 4 ↗ |
| ROCKLAGE SCOTT M10% owner | Purchase | +110.4K | n/c | — | 3.4Mindirect | Jul 20, 2018 | Jul 20, 2018 | Form 4 ↗ |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner | Purchase | +400.0K | n/c | — | 2.3Mindirect | Jul 20, 2018 | Jul 20, 2018 | Form 4 ↗ |
| Krasner Alan SethChief Medical Officer | Purchase | +2,000 | n/c | — | 2,000direct | Jul 20, 2018 | Jul 20, 2018 | Form 4 ↗ |
| PERCEPTIVE ADVISORS LLCDirector · 10% owner | Purchase Amended | +307.6K | $21.30 | $6.6M | 307.6Kindirect | Jul 18, 2018 | Aug 27, 2018 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →